Trial intelligence / Profile preview

SLV320 Hemodynamics in CHF

NCT00160134Phase 2Completed

Sponsor
Solvay
Start
Jan 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of rolofylline in heart failure (HF), sponsored by Solvay. Started Jan 2005; status: completed.

02

Drugs

rolofylline
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00160134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00160134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call